12:00 AM
Aug 29, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Dermagraft: Development discontinued

Shire said it will discontinue development of Dermagraft to treat venous leg ulcers after top-line data from the open-label, international Phase III DEVO trial in >500 patients showed that weekly Dermagraft combined with Profore compression therapy missed the primary endpoint of complete...

Read the full 187 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >